Causes of Spastic Paraplegia in Children
Spastic paraplegia in children results from a complex interplay of prenatal/perinatal brain injury (most common), genetic mutations (increasingly recognized at ~14% of cases), and metabolic disorders, with the complete causal pathway remaining unclear in approximately 80% of cases 1.
Primary Etiologic Categories
1. Acquired Brain Injury (Most Common)
The majority of childhood spastic paraplegia occurs as part of cerebral palsy, attributed to nonprogressive disturbances in the developing fetal or infant brain 1. Key risk factors include:
- Prematurity and low birth weight
- Prenatal complications during conception and pregnancy
- Perinatal events (though birth asphyxia accounts for <10% of cases, contrary to historical belief) 1
- Postneonatal insults
- Infectious disease burden (particularly in low-to-middle income countries) 1
Critical pitfall: Birth asphyxia has been historically overemphasized as a cause—it actually represents less than 10% of cases 1.
2. Genetic Causes (14% of Cases)
Recent evidence demonstrates genetic variants contribute significantly more than previously recognized 1:
Hereditary Spastic Paraplegia (HSP)
- Over 100 genes identified causing HSP subtypes 2
- SPG4 (SPAST gene): Most common variant, can present in infancy despite being autosomal dominant 3, 4
- ALS2 gene mutations: Cause infantile onset ascending hereditary spastic paraparesis 5
- Inheritance patterns: Autosomal dominant (often pure forms) or autosomal recessive (commonly associated with complicated forms and rapid progression) 6
Key clinical distinction: Pure HSP presents with isolated lower limb spasticity, while complicated forms include additional neurological abnormalities (cognitive impairment, cerebellar dysfunction, polyneuropathy) 6, 2.
Genomic Variants
- Copy number variants (CNVs): Identified in 10-31% of cerebral palsy cases 7
- Single nucleotide variants (SNVs): Pathogenic variants found in 7-55% of cases using exome sequencing 7
- De novo mutations: Relatively frequent in HSP genes, can present without family history 3
Critical diagnostic point: Exome sequencing now recommended as standard of care for neurodevelopmental disorders including cerebral palsy, with diagnostic yield of 42.1% when exclusion criteria are applied 7.
3. Inborn Errors of Metabolism
Metabolic disorders can present as isolated spastic paraparesis for years before other symptoms emerge 8:
- Hyperprolinemia (as seen with ALS2 mutations) 5
- Various other metabolic conditions that are often treatable
Essential caveat: These metabolic causes are frequently missed but critically important to identify as many are treatable 8.
Diagnostic Approach Algorithm
Step 1: Clinical History
Look specifically for:
- Timing of symptom onset (mean age 3 years for pure forms, 5 years for complicated forms) 6
- Red flags for complicated HSP: Early non-motor developmental delay, rapidly ascending paraparesis spreading to arms/bulbar structures 6
- Family history (though absence doesn't exclude genetic causes due to de novo mutations) 3
- Prenatal, perinatal, and postneonatal risk factors 1
Step 2: Neuroimaging
- MRI brain and spine: 86-89% sensitivity for detecting cerebral palsy risk 1
- Look for: ventricular enlargement, corpus callosum dysplasia, microcephaly (suggest neurodevelopmental etiology) 9
Step 3: Genetic Testing
- Exome sequencing as first-tier test for children with spastic paraplegia and neurodevelopmental features 7
- HSP gene panel when pure spastic paraplegia without other neurodevelopmental features 5, 2
- Consider testing even without family history given frequency of de novo mutations 3
Step 4: Metabolic Screening
Clinical Presentation Patterns
Spasticity distribution in cerebral palsy 1:
- Bilateral diplegia (lower limbs > upper limbs): 37%
- Unilateral hemiplegia: 38%
- Quadriplegia (all limbs and trunk): 24%
- Most subtypes have earliest onset in infancy or early childhood
- Symptoms range from juvenile forms in first years of life to later-onset forms
- Expression of HSP genes peaks during post-conception weeks 8-24 (neuroprogenitor proliferation period) 9
Common Diagnostic Pitfall
Misdiagnosis as cerebral palsy is particularly common when HSP presents in infancy without positive family history 3. The key distinguishing feature: HSP represents a neurodevelopmental disorder with genetic basis, not purely degenerative, and warrants specific genetic investigation even when phenotypically resembling cerebral palsy 9.